Live Interview With SinoFresh Execs to Air on Leading Syndicated Business Talk Radio Show, Sunday, November 16th ENGLEWOOD, Fla., Nov. 14 /PRNewswire-FirstCall/ -- SinoFresh HealthCare, Inc. (OTC Bullein Board: SFSH), producer of SinoFresh(R) Nasal and Sinus Care, an over-the-counter medication that attacks the many causes of chronic sinus-related and post-nasal disorders, today announced that its CEO and CMO will be featured in a live, nationally syndicated interview on Greenwave Radio, airing on Sunday, November 16, 2003. (Photo: http://www.newscom.com/cgi-bin/prnh/20030710/NYTH024 ) Charles Fust, the Chief Executive Officer and inventor of SinoFresh, and Dr. Michael G. Stampar, a board-certified ENT and the company's Chief Medical Officer, will discuss the product and opportunities for investors. GreenWave Radio is a syndicated radio show on business and the environment. It can be heard on 50 stations nationwide on Business Talk Radio and at MSNBC.com. between 10 a.m. and noon (EST). The interview airs in the following markets: Station Frequency City State Zip Code CALL FREQ DMA MARKET DMA KYCA AM 1490 "PHOENIX, AZ" AZ 85001 WATZ AM 1550 ALPENA LIMA MARQUETTE OH ZANVL MI-OH WABJ AM 1490 "TOLEDO, OH" OH 43601 KGWA AM 960 "OKLAHOMA CITY, OK" OK 73101 KMJC AM 620 "MEDFORD-KLAMATH FALLS, OR" OR 97501 KSYC AM 1490 "MEDFORD-KLAMATH FALLS, OR" OR 97601 KBNP AM 1410 "PORTLAND, OR" OR 97201 WPSE AM 1450 "ERIE, PA" PA 16501 WHVR AM 1280 "HARRISBURG-LANCASTER- LEBANON-YORK, PA" PA 17101 WMAJ AM 1450 "JOHNSTOWN-ALTOONA, PA" PA 16601 WRTA AM 1240 "JOHNSTOWN-ALTOONA, PA" PA 16601 KZTK AM 970 BAKERSFIELD CA 93301 WWDB AM 860 "PHILADELPHIA, PA" PA 19019 WADK AM 1540 Providence RI 02901 WISW AM 1320 COLUMBIA SC 29201 WAIM AM 1230 "GREENVILLE-SPRTNBRG- ASHVL-ANDRSN, SC" SC 29201 KJJQ AM 910 Brookings SD 29201 KIMM AM 1150 "RAPID CITY, SD" SD 57701 KIJV AM 1340 Sioux Falls SD 57101 WDXI AM 1310 "JACKSON, TN" TN 38301 WGNS AM 1450 "NASHVILLE, TN" TN 37201 KQMS AM 1400 Chico-Redding CA 96002 WKIN AM 1320 "TRI-CITIES, TN-VA" TN KEYS AM 1440 "CORPUS CHRISTI, TX" TX 78350 About SinoFresh HealthCare, Inc. SinoFresh (http://www.sinofresh.com/) develops, produces and markets products that treat the causes - yeasts, molds, and bacteria -- not just the symptoms of sinus related disorders, an ailment suffered by more than 37 million Americans. After eight years of research and development and numerous patents, SinoFresh launched its nasal and sinus spray, SinoFresh Nasal and Sinus Care, in a beta test market on the southwest coast of Florida in early 2003. Demand for SinoFresh Nasal and Sinus Care grew as Ear, Nose and Throat specialists recognized its potential as an effective treatment for the cause of sinus related disorders and began recommending it to their patients. Cautionary Statement Regarding Forward Looking Statements The foregoing press release contains "forward-looking statements." In some cases, you can identify forward-looking statements by terminology such as "may," "will," "should," "could," "expects," "plans," "intends," "anticipates," "believes," "estimates," "predicts," "potential" or "continue" or the negative of such terms and other comparable terminology. These forward-looking statements include, without limitation, statements about our market opportunity, our strategies, competition, expected activities and expenditures as we pursue our business plan, and the adequacy of our available cash resources. Although we believe that the expectations reflected in the forward-looking statements are reasonable, we cannot guarantee future results, levels of activity, performance or achievements. Actual results may differ materially from the predictions discussed in these forward-looking statements. The economic environment within which we operate could materially affect our actual results. Additional factors that could materially affect these forward-looking statements include, among other things, (1) general economic and business conditions; (2) the success of our brand awareness campaign; (3) the ability of the Company to raise additional capital through the offering of equity securities; (4) competition; (5) the ability of the Company to continue to build strategic relationships with major retail chain stores; (6) required accounting changes; (7) the Company's relationship with AccuMed; (8) approval of our products by the FDA for OTC sales; (9) the protection of our intellectual property rights; and (10) other factors over which the Company has little or no control. SinoFresh HealthCare, Inc. Contact: Tony Francel, Investor Relations, 941-488-4008 Rubenstein Associates, Inc. Public Relations Contact: Nadine Woloshin 212-843-8041 Photo: http://www.newscom.com/cgi-bin/prnh/20030710/NYTH024 DATASOURCE: SinoFresh HealthCare, Inc. CONTACT: Tony Francel, Investor Relations of SinoFresh HealthCare, +1-941-488-4008; or Nadine Woloshin of Rubenstein Associates, Inc. Public Relations, +1-212-843-8041, for SinoFresh HealthCare, Inc. Web site: http://www.sinofresh.com/

Copyright